ethylmaleimide has been researched along with benzyloxycarbonylleucyl-leucyl-leucine aldehyde in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Kim, OJ | 1 |
2 other study(ies) available for ethylmaleimide and benzyloxycarbonylleucyl-leucyl-leucine aldehyde
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
A single mutation at lysine 241 alters expression and trafficking of the D2 dopamine receptor.
Topics: Animals; Cell Line; Cysteine Proteinase Inhibitors; Enzyme Inhibitors; Ethylmaleimide; Humans; Leupeptins; Lysine; Mutagenesis, Site-Directed; Mutation; Proteasome Endopeptidase Complex; Protein Transport; Rats; Receptors, Dopamine D2; Signal Transduction; Transfection; Ubiquitin; Ubiquitination | 2008 |